Differential roles of osteopontin/Eta-1 in early and late lpr disease

Clinical and Experimental Immunology

Volumn 126, Issue 3, 2001, Pages 578-583

  Weber, G F ^a   Cantor, H ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Immunoglobulin; Knockout mase; Lymphoproliferation; Osteopontin

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN; OSTEOPONTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; ENCEPHALITIS; GENE MUTATION; KIDNEY DISEASE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; FEMALE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, KNOCKOUT; MUTATION; OSTEOPONTIN; SIALOGLYCOPROTEINS;

EID: 0035655155     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01702.x     Document Type: Article

References (22)

1. - lymphocytes during the development of murine autoimmune disease
2. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease
3. Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies
4. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
5. Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
6. Age-dependent isotype variation during secondary immune response in MRL/lpr mice producing autoanti-gamma-globulin antibodies
7. Determinants recognized by murine rheumatoid factors: Molecular localization using a panel of mouse myeloma variant immunoglobulins
8. Induction of various autoantibodies by mutant gene lpr in several strains of mice
9. Interaction of mutant lpr gene with background strain influences renal disease
10. + T cell depletion on inflammatory central nervous system disease, arthritis and sialadenitis in MRL/lpr mice
11. Inflammatory central nervous system disease in lupus-prone MRL/ lpr mice: Comparative histologic and immunohistochemical findings
12. 2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice
13. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice
14. Renal lesions in MRL mice
15. Detection of circulating immune complexes in MRL mice with different forms of glomer-ulonephritis
16. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice
17. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas (lpr) mice
18. Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death
19. CS-A therapy in MRL-lpr/lpr mice: Amelioration of immunopathology despite autoantibody production
20. Expression of Th1/Th2 cytokine mRNA in peritoneal exudative polymorphonuclear neutrophils and their effects on mononuclear cell Th1/Th2 cytokine production in MRL-lpr/lpr mice
21. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice
22. Liver of MRL/lpr mice contain interleukin-4-producing lymphocytes and accessory cells that support the proliferation of Th2 helper T lymphocyte clones